首页 | 本学科首页   官方微博 | 高级检索  
     

化疗对中晚期消化系肿瘤患者细胞免疫的影响
引用本文:成涛,潘斌,韩洪涛. 化疗对中晚期消化系肿瘤患者细胞免疫的影响[J]. 肿瘤研究与临床, 2002, 14(5): 325-327
作者姓名:成涛  潘斌  韩洪涛
作者单位:1. 陕西省人民医院,陕西 西安 710068
2. 西安交通大学医学院,陕西 西安 710061
摘    要:目的 :观察化疗对中晚期消化系肿瘤患者细胞免疫的影响。方法 :30例接受化疗的中晚期消化系肿瘤患者 ,分别在化疗前后检测外周血 T淋巴细胞亚群比例 ,血浆可溶性白细胞介素 -2受体 (s IL- 2 R)含量 ,并设正常健康组为对照。结果 :化疗前与正常健康组相比 ,肿瘤患者 T淋巴细胞亚群比例紊乱 ,CD 4 比例下降 ,CD 8比例升高 ,CD 4 / CD 8比值下降 ,s IL- 2 R含量升高 ;与化疗前比较 ,化疗后肿瘤患者 CD 4 比例、CD 4 / CD 8比值进一步下降 ,CD 8比例、s IL - 2 R含量进一步升高。结论 :化疗可加重中晚期肿瘤患者的免疫抑制 ,化疗后应辅以免疫治疗

关 键 词:消化系肿瘤  化疗  细胞免疫
文章编号:1006-9801(2002)05-0325-03
修稿时间:2002-02-08

The Effect of Chemotherapy on Immunity of Patients with Intermediate and Late Malignant Tumor of Digestive Tract
Abstract:Objective:To assess the effect of chemotherapy on immunity of patients with intermediate and late malignant tumor of digestive tract.Methods:Thirty patients were treated with chemotherapy.The values of CD 4 cell,CD 8 cell,CD 4/CD 8 and sIL-2R were tested before and after treatment respectively.The normal values of them were also determined.Results: Before treatment, the values of CD 4,CD 4/CD 8 declined and the values of CD 8, sIL-2R increased compared with normal controls. Compared with the values before chemotherapy,the values of CD 4, CD 4/CD 8 decreased obviously and the values of CD 8, sIL-2R increased. The significant differences were occurred (P<0.05 or P<0.001).Conclusion:Chemotherapy can decrease cellular immunity of malignant tumor patient.Immunity therapy should be used after chemotherapy.
Keywords:Malignant tumor of digestive tract  Chemotherapy  Cellular immunity
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号